Menta Capital’s AngioDynamics ANGO Stock Holding History

Menta Capital’s Portfolio ANGO Stock Details ANGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-41,631	Closed	-$711K	–	626
2017 Q3	$711K	Sell	41,631 -1,400	-3%	-$23.5K	0.1%	350
2017 Q2	$698K	Buy	+43,031	New	+$680K	0.08%	426
2017 Q1	–	Sell	-59,768	Closed	-$1.01M	–	798
2016 Q4	$1.01M	Sell	59,768 -21,999	-27%	-$367K	0.08%	424
2016 Q3	$1.43M	Buy	+81,767	New	+$1.33M	0.14%	254

Other funds holding ANGO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FWIA

Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

Menta Capital's ANGO Position: Q4 2017 in Review

Menta Capital sold out of AngioDynamics (ANGO) in Q4 2017, closing a stake of 41,631 shares — an estimated $711K sold.

Menta Capital first reported a position in ANGO in Q3 2016 and held it in 4 quarters. The position peaked at $1.43M in Q3 2016. 169 funds tracked by Wall St. Rank hold ANGO as of Q4 2017.

Menta Capital reported no remaining AngioDynamics position as of Q4 2017 after selling out during the quarter.
Menta Capital sold 41,631 AngioDynamics shares in Q4 2017, an estimated $711K.
Menta Capital first reported a position in AngioDynamics in Q3 2016 and held it in 4 quarters.
Menta Capital's AngioDynamics position peaked at $1.43M in Q3 2016.
169 funds tracked by Wall St. Rank held AngioDynamics as of Q4 2017.

Based on Menta Capital's 13F filing for Q4 2017, filed 14 Feb 2018.